オプションチェーンは、Under Armourの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Under Armourの市場センチメントを評価します。.

Under Armour (NYSE:UAA) 株価情報, オプションチェーン

Under Armour

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Under Armour Inc

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $64 to $69.

News

Price Target

Analyst Ratings

RYTM

HC Wainwright & Co. Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $69

PepGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEPG#NASDAQ">PEPG</a>) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.87) by 24.14 percent. This is a 32.65 percent increase over losses of $(0.98) per share from the same period last year.

Earnings

Earnings Beats

PEPG

PepGen Q3 EPS $(0.66) Beats $(0.87) Estimate

Dividends

TGLS

Tecnoglass Board Approves 36% Increase In Quarterly Dividend From $0.11 To $0.15 Per Share

Biotech

Health Care

General

ENSC

Ensysce Biosciences Has Received Notice From The Nasdaq Stock Market That The Company May Continue Its Listing On The Nasdaq Capital Market Tier With An Extension To November 14

Global Indemnity Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBLI#NYSE">GBLI</a>) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.57 by 66.67 percent. This is a 69.64 percent increase over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $111.761 million which missed the analyst consensus estimate of $123.000 million by 9.14 percent. This is a 11.34 percent decrease over sales of $126.061 million the same period last year.

Earnings Misses

GBLI

Global Indemnity Group Q3 2024 Adj. EPS $0.95 Beats $0.57 Estimate, Sales $111.761M Miss $123.000M Estimate

Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) reported quarterly losses of $(0.27) per share. This is a 164.29 percent decrease over earnings of $0.42 per share from the same period last year. The company reported $31.41 million in sales this quarter. This is a 5.88 percent decrease over sales of $33.37 million the same period last year.

NSYS

Nortech Systems Q3 EPS $(0.27) Down From $0.42 YoY, Sales $31.41M Down From $33.37M YoY

MEDIROM Healthcare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) announced a business alliance with SBC Medical Group Holdings Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBC#NASDAQ">SBC</a>) a global owner, operator and provider of management services and products to cosmetic treatment centers.
Our two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC's "Shonan Beauty Clinic" and MEDIROM's "Re.Ra.Ku wellness salon". In addition to bringing customers enhanced offerings and expertise, the alliance will seek to create compelling, integrated opportunities to harness the power of these loyal customers and reward them when they receive services at SBC Medical and MEDIROM.

MEDIROM Healthcare Technologies And SBC Medical Group Holdings Announce Business Alliance, Bringing Customers Enhanced Offerings And Expertise, The Alliance Will Seek To Create Compelling, Integrated Opportunities To Harness The Power Of These Loyal Customers And Reward Them When They Receive Services At SBC Medical And MEDIROM

LakeShore Biopharma Initiates Biologics License Application Of PIKA Rabies Vaccine To The Drug Regulatory Authority Of Pakistan

XELA

On November 6, 2024, The Nasdaq Stock Market Notified Exela Technologies That The Nasdaq Hearings Panel Has Determined To Delist The Company's Common Stock And That Trading Of The Company's Securities Will Be Suspended At The Open Of Trading On November 8-Filing

OTR Global downgrades Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) from Mixed to Negative.

Downgrades

PANW

OTR Global Downgrades Palo Alto Networks to Negative

Schwab Asset Management&#xAE;, the asset management arm of The Charles Schwab Corporation, today announced the launch of the Schwab Mortgage-Backed Securities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBS#NYSE">SMBS</a>). The first day of trading is expected to be on or about November 19.
With an expense ratio of 0.03%, the Schwab Mortgage-Backed Securities ETF is priced in line with the lowest-priced peer ETFs based on the U.S. Mortgage Lipper category1. The ETF will provide simple access to investment-grade mortgage-backed securities issued and/or guaranteed by U.S. government agencies. It is designed to serve as part of a diversified portfolio.

ETFs

SCHW

SMBS

Schwab Asset Management To Launch The Schwab Mortgage-Backed Securities ETF "SMBS" On Or About November 19

Buybacks

STGW

Stagwell Reveals $125M Increase In Stock Repurchase Program

Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Hold.

Reiteration

GILD

Needham Reiterates Hold on Gilead Sciences

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587386a45064ed0001b4b61b/lauren-lieberman">Barclays analyst Lauren Lieberman</a> downgraded the rating for Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) from Equal-Weight to Underweight and lowered the price target from $8 to $7. Coty shares closed at $7.43 on Wednesday. <a href="https://www.benzinga.com/quote/COTY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Sean Milligan downgraded Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Hold to Underperform and cut the price target from $93 to $61. Enphase Energy shares closed at $74.81 on Wednesday. <a href="https://www.benzinga.com/quote/ENPH/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Laura Champine downgraded the rating for Crocs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) from Buy to Hold and lowered the price target from $150 to $110. Crocs shares closed at $102.74 on Wednesday. <a href="https://www.benzinga.com/quote/CROX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Bernstein analyst Toni Sacconaghi downgraded Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) from Outperform to Market Perform and announced a price target of $11. Ford shares closed at $11.19 on Wednesday. <a href="https://www.benzinga.com/quote/F/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59009b5a0bd9910001e5f2aa/bradley-thomas">Keybanc analyst Bradley Thomas </a>downgraded the rating for Dollar Tree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) from Overweight to Sector Weight. Dollar Tree shares closed at $62.41 on Wednesday. <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying Ford stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-1024x586.png" alt="" class="wp-image-635158" style="width:545px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/07080339/image-76.png 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41776764/jim-cramer-this-financial-stock-is-a-buy-likes-broadcom">Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom</a></li>
</ul>

Pre-Market Outlook

Markets

Trading Ideas

COTY

CROX

DLTR

ENPH

This Ford Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

NKT Photonics to deliver three innovative prototype optical subsystems to IonQ in 2025
NKT Photonics' advanced laser systems will be integrated into IonQ's upcoming data center-ready quantum systems
IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), a leader in the quantum computing industry, announced today a partnership with <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nktphotonics.com%2F&amp;esheet=54148577&amp;newsitemid=20241107761716&amp;lan=en-US&amp;anchor=NKT+Photonics&amp;index=1&amp;md5=e2aeed3e06c83873b1e9149d1f342cf4">NKT Photonics</a>, a subsidiary of Hamamatsu Photonics, to procure next-generation laser systems for IonQ's trapped-ion quantum computers and networking equipment. The partnership involves NKT Photonics developing and delivering three prototype optical subsystems to IonQ in 2025, designed to support the commercialization of IonQ's data center-ready quantum computers – such as IonQ Tempo and future barium-based systems.

IONQ

IonQ Announces Partnership With NKT Photonics For Next-Generation Laser Systems To Power Future Quantum Computers

Guidance

Stagwell Reaffirms FY24 Guidance For Organic Net Revenue Growth Of 5% To 7%; Adjusted EBITDA Of $400M - $450M; Free Cash Flow Conversion Of ~50%

Lipocine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPCN#NASDAQ">LPCN</a>) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.48) by 8.33 percent. This is a 65.35 percent increase over losses of $(1.27) per share from the same period last year.

LPCN

Lipocine Q3 EPS $(0.44) Beats $(0.48) Estimate

FSTR

L.B. Foster Sees FY 2024 Net Sales $530M-$540M Vs $540.92M Est.

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAZZ#NASDAQ">JAZZ</a>) with a Buy and maintains $207 price target.

JAZZ

Needham Reiterates Buy on Jazz Pharmaceuticals, Maintains $207 Price Target

COEP

Coeptis Therapeutics Announces Phase 1 Data On DVX201 For COVID-19 Treatment Has Been Accepted For Publication in 'Molecular Therapy Methods and Clinical Development'

UBS raised the firm's price target on Under Armour (UA) (UAA) to $12 from $11 and keeps a Buy rating on the shares. The firm's checks suggest Under...

Under Armour price target raised to $12 from $11 at UBS

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Hermes International (HESAF – Research Repo...

Analysts Offer Insights on Consumer Cyclical Companies: Hermes International (OtherHESAF), Under Armour (UAA) and Tesla (TSLA)

Earnings week ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and more

John Kernan, an analyst from TD Cowen, maintained the Hold rating on Under Armour (UAA – Research Report). The associated price target was raised t...

Under Armour's Strategic Shift Amidst Market Challenges: A Hold Rating Analysis

In a report released today, Joe Feldman from Telsey Advisory maintained a Hold rating on Under Armour (UAA – Research Report), with a price target ...

Telsey Advisory Sticks to Their Hold Rating for Under Armour (UAA)

Seaport Global analyst Mitch Kummetz maintained a Hold rating on Under Armour (UAA – Research Report) today. The company's shares closed yesterday ...

Under Armour (UAA) Gets a Hold from Seaport Global

Notable companies reporting before tomorrow's open, with earnings consensus, include Transdigm (TDG), consensus $9.32… Becton Dickinson (BDX), cons...

Notable companies reporting before tomorrow's open

Under Armour Non-GAAP EPS of $0.30 beats by $0.11, revenue of $1.4B beats by $20M

Reports Q2 revenue $1.4B, consensus $1.38B. Inventory decreased 3% to $1.1B. "Our second quarter fiscal 2025 performance demonstrates that our stra...

Under Armour reports Q2 adjusted EPS 30c, consensus 20c

Consensus 24c. Sees FY25 revenue down low double-digit percentage range. The company said, "Capital expenditures are expected to be between $190 an...

Under Armour raises FY25 adjusted EPS view to 24c-27c from 19c-21c

ABNB

AFRM

ANET

BLNK

BNTX

BYND

CRSP

CTVA

DDOG

DKNG

ELAN

FANG

GDRX

HESAF

ILMN

KVUE

LCID

LUMN

LYFT

MAIN

MARA

MRNA

NVAX

NXPI

OPEN

PARA

PENN

PINS

PLNT

PLTK

PLTR

PZZA

QCOM

RIVN

SEDG

SONY

SPCE

TEVA

TSLA

TTWO

TWLO

UPST

USFD

VRTX

VTRS

WYNN

YETI

Press Releases

UNDER ARMOUR REPORTS FOURTH QUARTER AND FULL-YEAR FISCAL 2024 RESULTS; PROVIDES INITIAL FISCAL 2025 OUTLOOK

USA FOOTBALL AND UNDER ARMOUR FORM MULTI-YEAR PARTNERSHIP TO SUPPORT U.S. NATIONAL TEAMS AND GROW THE GAME OF FOOTBALL

University of Maryland and Under Armour Announce 12-Year Extension of Iconic Partnership

UNDER ARMOUR ANNOUNCES AGREEMENT TO SETTLE CLASS ACTION LITIGATION

UNDER ARMOUR ANNOUNCES FIRST QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE

UNDER ARMOUR ANNOUNCES ERIC LIEDTKE AS EXECUTIVE VICE PRESIDENT OF BRAND STRATEGY

UNDER ARMOUR REPORTS FIRST QUARTER 2025 RESULTS; UPDATES FISCAL 2025 OUTLOOK

UNDER ARMOUR ANNOUNCES UPDATE TO ITS RESTRUCTURING PLAN AND FISCAL 2025 OUTLOOK

UNDER ARMOUR ANNOUNCES SECOND QUARTER FISCAL 2025 EARNINGS CONFERENCE CALL DATE

UNDER ARMOUR REPORTS SECOND QUARTER 2025 RESULTS; RAISES FISCAL 2025 OUTLOOK

Amer Sports

Columbia Sportswear Company - Common Stock

Columbia Sportswear

Capri Holdings

Carter's

Dogness (International) Corporation - Class A Common Stock

Dogness (Intl)

FIGS

Fossil Group

G-III Apparel Group

Hanesbrands

Kontoor Brands

Lakeland Industries

Lanvin Group Holdings Limited Ordinary Shares

Lanvin Gr Hldgs

Levi Strauss

Lululemon Athletica

Movado Group

Oxford Industries

PLBY Group

Ralph Lauren

Superior Group of Companies, Inc. - Common Stock

Superior Gr of Cos

Tapestry

Vera Bradley

Ermenegildo Zegna

TD Cowen

Telsey Advisory Group

BMO Capital

Wedbush

WIIM

Under Armour shares are trading higher after the company reported better-than-expected Q2 EPS and sales.

Comments

Under Armour

Under Armour (UAA) オプション

Under Armour (NYSE:UAA) 株価情報, オプションチェーン

ニュース

パートナーシップ

ベンジンガ・グローバル